Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucose Transporter Type 4 | 26 | 2021 | 63 | 5.460 |
Why?
|
| Adipocytes | 12 | 2024 | 60 | 3.690 |
Why?
|
| Glucose | 8 | 2024 | 209 | 3.050 |
Why?
|
| Adipose Tissue | 7 | 2024 | 197 | 2.010 |
Why?
|
| Insulin | 12 | 2021 | 325 | 1.710 |
Why?
|
| Phosphofructokinase-2 | 2 | 2024 | 12 | 1.540 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 646 | 1.410 |
Why?
|
| Insulin Resistance | 5 | 2024 | 176 | 1.370 |
Why?
|
| Monosaccharide Transport Proteins | 8 | 2020 | 23 | 1.230 |
Why?
|
| Muscle Proteins | 7 | 2005 | 56 | 1.190 |
Why?
|
| 3T3-L1 Cells | 6 | 2021 | 30 | 1.090 |
Why?
|
| Promoter Regions, Genetic | 11 | 2017 | 344 | 1.030 |
Why?
|
| Mice | 24 | 2024 | 4870 | 1.020 |
Why?
|
| Histone Deacetylases | 3 | 2012 | 26 | 0.940 |
Why?
|
| Animals | 29 | 2024 | 10806 | 0.900 |
Why?
|
| Signal Transduction | 8 | 2018 | 1502 | 0.840 |
Why?
|
| Homeostasis | 1 | 2024 | 122 | 0.810 |
Why?
|
| Obesity | 3 | 2019 | 705 | 0.780 |
Why?
|
| Muscle, Skeletal | 6 | 2016 | 645 | 0.770 |
Why?
|
| Myogenic Regulatory Factors | 6 | 2009 | 20 | 0.700 |
Why?
|
| Mice, Knockout | 1 | 2024 | 881 | 0.700 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 58 | 0.600 |
Why?
|
| Genes, Reporter | 3 | 2018 | 88 | 0.600 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 69 | 0.590 |
Why?
|
| Microtubules | 3 | 2006 | 90 | 0.590 |
Why?
|
| Weight Loss | 1 | 2019 | 84 | 0.580 |
Why?
|
| Gene Expression | 2 | 2018 | 418 | 0.560 |
Why?
|
| Cytoskeleton | 3 | 2009 | 45 | 0.550 |
Why?
|
| Adipocytes, White | 1 | 2017 | 10 | 0.530 |
Why?
|
| Molecular Imaging | 1 | 2018 | 35 | 0.520 |
Why?
|
| NADP | 1 | 2017 | 39 | 0.520 |
Why?
|
| Adipogenesis | 1 | 2017 | 27 | 0.520 |
Why?
|
| Physical Conditioning, Animal | 2 | 2016 | 47 | 0.520 |
Why?
|
| NAD | 1 | 2017 | 104 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 1684 | 0.490 |
Why?
|
| Triglycerides | 2 | 2016 | 123 | 0.490 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2013 | 7 | 0.490 |
Why?
|
| DNA-Binding Proteins | 5 | 2009 | 490 | 0.470 |
Why?
|
| Amino Acids | 1 | 2016 | 85 | 0.470 |
Why?
|
| Diet, High-Fat | 2 | 2016 | 144 | 0.470 |
Why?
|
| Transcription Factors | 5 | 2009 | 524 | 0.470 |
Why?
|
| Mice, Transgenic | 9 | 2016 | 514 | 0.460 |
Why?
|
| Hyperinsulinism | 1 | 2014 | 17 | 0.420 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2014 | 30 | 0.420 |
Why?
|
| Endosomes | 1 | 2014 | 53 | 0.410 |
Why?
|
| Actins | 2 | 2005 | 99 | 0.410 |
Why?
|
| Cell Differentiation | 2 | 2021 | 430 | 0.410 |
Why?
|
| PPAR alpha | 1 | 2013 | 44 | 0.380 |
Why?
|
| Biological Transport | 5 | 2020 | 128 | 0.380 |
Why?
|
| Mitochondria | 1 | 2016 | 419 | 0.380 |
Why?
|
| Glycolysis | 2 | 2024 | 96 | 0.370 |
Why?
|
| Cyclic AMP | 1 | 2012 | 96 | 0.350 |
Why?
|
| Fasting | 1 | 2012 | 91 | 0.340 |
Why?
|
| Down-Regulation | 3 | 2012 | 203 | 0.340 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 2010 | 8 | 0.340 |
Why?
|
| Liver X Receptors | 3 | 2017 | 22 | 0.320 |
Why?
|
| Male | 8 | 2024 | 14126 | 0.300 |
Why?
|
| Adiponectin | 2 | 2021 | 29 | 0.300 |
Why?
|
| Protein Transport | 3 | 2018 | 158 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 158 | 0.280 |
Why?
|
| Cell Line | 2 | 2021 | 705 | 0.260 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 159 | 0.260 |
Why?
|
| Humans | 16 | 2023 | 29211 | 0.260 |
Why?
|
| Transcription, Genetic | 4 | 2012 | 406 | 0.250 |
Why?
|
| Transcriptional Activation | 2 | 2003 | 86 | 0.240 |
Why?
|
| Cells, Cultured | 3 | 2017 | 1024 | 0.230 |
Why?
|
| Phosphorylation | 5 | 2013 | 586 | 0.230 |
Why?
|
| Cell Membrane | 2 | 2006 | 268 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 94 | 0.210 |
Why?
|
| MEF2 Transcription Factors | 5 | 2008 | 12 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 140 | 0.210 |
Why?
|
| Tubulin | 1 | 2003 | 32 | 0.200 |
Why?
|
| Blotting, Western | 3 | 2016 | 515 | 0.200 |
Why?
|
| 3T3 Cells | 4 | 2005 | 46 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 136 | 0.190 |
Why?
|
| Polymers | 1 | 2003 | 118 | 0.180 |
Why?
|
| COS Cells | 3 | 2008 | 49 | 0.180 |
Why?
|
| Dementia | 1 | 2023 | 98 | 0.180 |
Why?
|
| Xanthines | 1 | 2021 | 3 | 0.170 |
Why?
|
| Apelin | 1 | 2021 | 5 | 0.170 |
Why?
|
| Apelin Receptors | 1 | 2021 | 11 | 0.170 |
Why?
|
| Liver | 2 | 2016 | 497 | 0.170 |
Why?
|
| Dexamethasone | 1 | 2021 | 63 | 0.170 |
Why?
|
| Peritoneal Neoplasms | 1 | 2021 | 80 | 0.160 |
Why?
|
| Protein Binding | 3 | 2008 | 667 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 271 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2003 | 489 | 0.150 |
Why?
|
| Cell Nucleus | 3 | 2010 | 138 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 473 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 417 | 0.140 |
Why?
|
| Lipogenesis | 1 | 2017 | 29 | 0.130 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 24 | 0.130 |
Why?
|
| Hypoglycemia | 1 | 2017 | 34 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2017 | 62 | 0.130 |
Why?
|
| Aging | 1 | 2024 | 1041 | 0.130 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2016 | 10 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2017 | 79 | 0.120 |
Why?
|
| Glycogen | 1 | 2016 | 23 | 0.120 |
Why?
|
| Naphthyridines | 1 | 2016 | 4 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2017 | 247 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 20 | 0.120 |
Why?
|
| Mice, Obese | 1 | 2016 | 22 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 346 | 0.120 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 60 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 83 | 0.120 |
Why?
|
| Rats | 2 | 2018 | 1595 | 0.120 |
Why?
|
| Sirolimus | 1 | 2016 | 76 | 0.120 |
Why?
|
| Adiposity | 1 | 2016 | 96 | 0.110 |
Why?
|
| Nocodazole | 2 | 2006 | 11 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 610 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2016 | 310 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2010 | 669 | 0.110 |
Why?
|
| Receptors, Transferrin | 1 | 2014 | 18 | 0.110 |
Why?
|
| Thiazolidines | 2 | 2005 | 6 | 0.110 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2005 | 52 | 0.100 |
Why?
|
| Biomarkers | 1 | 2017 | 790 | 0.100 |
Why?
|
| Thiazoles | 2 | 2005 | 50 | 0.100 |
Why?
|
| Fatty Acid Synthases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 17 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 25 | 0.100 |
Why?
|
| Eating | 1 | 2013 | 71 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 134 | 0.080 |
Why?
|
| Epoxy Compounds | 1 | 2010 | 4 | 0.080 |
Why?
|
| Mitochondria, Liver | 1 | 2010 | 12 | 0.080 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 27 | 0.080 |
Why?
|
| Mitochondria, Muscle | 1 | 2010 | 44 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 83 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 147 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 198 | 0.080 |
Why?
|
| Ifosfamide | 1 | 2009 | 9 | 0.070 |
Why?
|
| Mitomycin | 1 | 2009 | 19 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 110 | 0.070 |
Why?
|
| Dimerization | 1 | 2008 | 76 | 0.070 |
Why?
|
| Cisplatin | 1 | 2009 | 186 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2008 | 119 | 0.070 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2007 | 2 | 0.060 |
Why?
|
| DNA | 2 | 2005 | 378 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2006 | 62 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2005 | 267 | 0.060 |
Why?
|
| Aorta | 1 | 2007 | 124 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 163 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2007 | 358 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 29 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 434 | 0.050 |
Why?
|
| Hypertension | 1 | 2007 | 309 | 0.050 |
Why?
|
| MADS Domain Proteins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 47 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 46 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 26 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 33 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 102 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 113 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 137 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 55 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 284 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 89 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 26 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 97 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2003 | 19 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 319 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 234 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2023 | 249 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 431 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 210 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 466 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 483 | 0.040 |
Why?
|
| Exercise | 1 | 2005 | 502 | 0.040 |
Why?
|
| Exocytosis | 1 | 2001 | 13 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 685 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 191 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 97 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 314 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2021 | 163 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 333 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 276 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1288 | 0.040 |
Why?
|
| Lipids | 1 | 2021 | 220 | 0.040 |
Why?
|
| Time Factors | 1 | 2003 | 1619 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 828 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 784 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 774 | 0.030 |
Why?
|
| Aged | 1 | 2023 | 5648 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Muscle Denervation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 4 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 355 | 0.020 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2007 | 4 | 0.020 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2005 | 7 | 0.010 |
Why?
|
| Ribonucleotides | 1 | 2005 | 7 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2005 | 43 | 0.010 |
Why?
|
| Female | 1 | 2021 | 15825 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 417 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 553 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2002 | 164 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 8130 | 0.010 |
Why?
|